Abstract
Background/Aim
Cardiotoxicity resulting in heart failure is a devastating outcome of cancer therapy. It is possible that a patient may survive cancer only to develop heart failure (HF), which ultimately has a higher mortality rate. The aim of this project was to a profile of the characteristics of at risk patients with cancer treatment induced heart failure.
Cardiotoxicity resulting in heart failure is a devastating outcome of cancer therapy. It is possible that a patient may survive cancer only to develop heart failure (HF), which ultimately has a higher mortality rate. The aim of this project was to a profile of the characteristics of at risk patients with cancer treatment induced heart failure.
| Original language | English |
|---|---|
| Pages (from-to) | S99-S99 |
| Number of pages | 1 |
| Journal | Journal of Cardiac Failure |
| Volume | 20 |
| Issue number | 8 |
| DOIs | |
| Publication status | Published - 2014 |
| Event | 18th Annual Scientific Meeting, Heart Failure Society of America - Duration: 14 Sept 2014 → … |
UN SDGs
This output contributes to the following UN Sustainable Development Goals (SDGs)
-
SDG 3 Good Health and Well-being
Keywords
- heart failure
- cancer therapy
- chemotherapy
Fingerprint
Dive into the research topics of 'Potential cardiotoxicity following cancer treatment: linked health data analysis'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver